Search results for "marker"
showing 10 items of 3799 documents
A biochemical study of the effects of tributyltin on unfertilized eggs, embryos and larvae of the sea squirt Ciona intestinalis
2009
We have used unfertilized eggs, embryos and larvae of the sea squirt Ciona intestinalis (Ascidiacea, Urochordata) to study the effects of tributyltin (TBT) on acetylcholine esterase (AChE) activity. Our results showed an increase of AChE enzyme activity levels after TBT exposure in both unfertilized eggs and embryos. The effects of TBT were more pronounced during the gastrula stage, while no differences between exposed larvae and controls were observed. A mechanism of TBT action on enzyme activity during ascidian embryonic development and the possibility of employing AChE in C. intestinalis as a biomarker of TBT exposure are suggested and discussed.
BIOMARKERS OF OXIDATIVE STRESS AS AN EARLY WARNING SYSTEM TO DETECT IN VITRO XENOBIOTICS’ TOXICITY: EFFECTS OF SUB LETHAL DOSES OF BIS (2-CHLORO-1-ME…
2014
Effects of sea cage farm on wild fish populations. A case study of bluefin tuna (thunnus thynnus) fattening in Castellammare del Golfo (Western Sicil…
2008
PPARα GENE VARIANTS AS PREDICTED PERFORMANCE ENHANCING POLYMORPHISMS IN PROFESSIONAL ITALIAN SOCCER PLAYERS
2012
SALINITY STRESS RESPONSE IN THREE SPECIES OF SPARIDAE CANDIDATE FOR ORGANIC AQUACULTURE
2014
Validation of glycated albumin reference interval in healthy Caucasian pregnant women
2022
No abstract available
Documento di consenso ANMCO/ELAS/SIBioC: Raccomandazioni sull'impiego dei biomarcatori cardiaci nello scompenso cardiaco
2016
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed. A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological or pathogenic processes, or pharmacological responses to a therapeutic intervention. Natriuretic peptides (B-type natriuretic peptide [BNP] and N-terminal proBNP) are the gold standard biomarkers in determining the diagnosis and prognosis of HF, and a natriuretic peptide-guided HF management looks promising. In the last few years, an array of additional biomarkers has emerged, each reflecting different pathophysiological processes in the development and progression of HF: myocardia…
Monocyte distribution width (MDW) as a reliable biomarker for urosepsis
2023
Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders
2022
(1) Background: Alpha-synuclein (α-syn) is a presynaptic neuronal protein that regulates several neuronal functions. In recent decades, the role of α-syn as a biomarker of neurodegenerative diseases has been explored, especially in synucleinopathies. However, only a few studies have assessed its role as biomarker in other neurological disorders. The aim of the study was to evaluate cerebrospinal fluid (CSF) α-syn levels in several neurological disorders; (2) Methods: We measured CSF α-syn levels by a commercial ELISA kit in 158 patients classified in the following group: controls, Alzheimer’s Disease (AD), cerebrovascular diseases, inflammatory central nervous …